Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- .beta.-hydroxybutyrate beta-hydroxybutyrate b-hydroxybutyrate b-HB beta-HB .beta.-HB ?-HB 3-hydroxybutyric acids ketones body bodies acetoacetates acetones ketosis lipids metabolisms fasting exercise diets diabetes childhood hypoglycemia corticosteroids growth hormones deficiency intoxication alcohols salicylates organ failure ketoacidosis metabolic acidosis blood serums subclinical glucose diabetic coma hyperosmolar non-ketotic insulin hyperketonemia neurodegenerative diseases inhibits inhibition adipocytes lipolysis plasmas urine assays
- Product Overview:
?-Hydroxybutyrate (?-HB; 3-hydroxybutyric acid) is a “ketone body” which is produced in the liver, mainly from the oxidation of fatty acids, and is exported to peripheral tissues for use as an energy source. The term ‘ketone body’ refers to three molecules, acetoacetate, ?-HB, and acetone. ?-HB and acetoacetate transport energy from the liver to the other tissues and acetone is generated by spontaneous decarboxylation of acetoacetate.{17093} The presence of ketosis may be normal or pathologic. Normally ketosis can indicate that lipid metabolism has been activated and the pathway of lipid degradation is intact. Normal ketosis is prevalent in many circumstances such as during fasting, after prolonged exercise or after a high fat diet. Pathological causes of ketosis include multiple organ failure, diabetes, childhood hypoglycemia, corticosteroid or growth hormone deficiency, intoxication with alcohol or salicylates and several inborn errors of metabolism.{17094} In acutely ill patients, these ketone bodies can accumulate in the body to cause ketoacidosis, which leads to the potentially life threatening condition known as metabolic acidosis.{17125} The presence and degree of ketosis can be determined by measuring blood levels of ?-HB. Ordinarily, ?-HB accounts for approximately 75% of the ketone bodies in serum.{17126,17127,17095} Measurement of ?-HB provides a reliable index of the level of ketoacidosis, including the detection of subclinical ketosis.{17096,17097,17128} In diabetics, ?-HB measurements (and blood glucose) can be used for the assessment of the severity of diabetic coma and is essential for the exclusion of hyperosmolar non-ketotic diabetic coma. The measurement of ?-HB is also used to monitor insulin requirements, based on existing hyperketonemia.{17098} ?-HB has more recently been evaluated for use in neurodegenerative diseases and inhibition of adipocyte lipolysis.{17099,17100,17101,17102,17103} Cayman’s ?-HB (Ketone Body) Assay Kit provides a simple, reproducible, and sensitive tool for measuring ?-HB levels in plasma, serum, urine, cell lysates, or tissue homogenates. The method for ?-HB determination is based upon the oxidation of D-3-Hydroxybutyrate to acetoacetate by the enzyme 3-hydroxybutyrate dehydrogenase.{17104} Concomitant with this oxidation, the cofactor NAD+ is reduced to NADH. In the presence of diaphorase, NADH reacts with the colorimetric detector WST-1 to produce a formazan dye with an absorbance maximum at 445-455 nm. The absorbance of the dye is directly proportional to the ?-HB concentration.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.